Generated by Rank Math SEO, this is an llms.txt file designed to help LLMs better understand and index this website.

# Roche Diagram:  Asia Pacific Diagnostic Insights

## Sitemaps
[XML Sitemap](https://rochediagram.com/sitemap_index.xml): Includes all crawlable and indexable pages.

## Posts
- [32 million reasons to act: why Asia-Pacific needs a new Heart Failure strategy](https://rochediagram.com/future-of-healthcare/32-million-reasons-to-act-why-asia-pacific-needs-a-new-heart-failure-strategy/): Heart Failure is creating unsustainable pressure on health systems across Asia-Pacific. A new white paper uncovers where current policy is falling short — with a roadmap to turn the tide.
- [How advanced mass spectrometry saves lives in organ transplant care ](https://rochediagram.com/inside-the-lab/how-advanced-mass-spectrometry-saves-lives-in-organ-transplant-care/): Traditional mass spectrometry (MS) has always been confined to specialised environments. But what if we could give patients these gold-standard diagnostic insights at scale? 
- [CGM: forging the path to personalised diabetes care](https://rochediagram.com/future-of-healthcare/cgm-forging-the-path-to-personalised-diabetes-care/): Diabetes prevalence rates are rising rapidly across Asia-Pacific, with immense human, clinical and economic costs. Our new white paper ‘Optimising Diabetes Management in Asia Pacific CGM: A Pathway to Personalised Care’ explains how Continuous Glucose Monitoring (CGM) offers a proven pathway to better outcomes — but only if health systems can ensure equitable access.
- [The Memory Vault: Why early detection matters in Alzheimer’s](https://rochediagram.com/inside-the-lab/the-memory-vault-why-early-detection-matters-in-alzheimers/): Vijaya’s journey began not with memory loss, but with subtle early signs of a disease.  Jayaram, her husband and primary caregiver, emphasizes, this is where timely intervention can give families something priceless: time to understand, adapt, and care.
- [From Days to Hours: How Sequencing by Expansion (SBX) Is Redefining Genomic Discovery](https://rochediagram.com/inside-the-lab/from-days-to-hours-how-sequencing-by-expansion-sbx-is-redefining-genomic-discovery/): Whole-genome sequencing has long been constrained by speed, cost, and access. SBX is designed to change all three.
- [The 130 million missing patients: why APAC’s Alzheimer’s challenge is bigger than we think](https://rochediagram.com/future-of-healthcare/the-130-million-missing-patients-why-apacs-alzheimers-challenge-is-bigger-than-we-think/): Across the Asia-Pacific region, 130 million people are biologically developing Alzheimer's disease without knowing it — and health systems are almost entirely unprepared to find them
- [Mind the Gap: Why Women’s Health Needs a System Redesign](https://rochediagram.com/roche-perspectives/mind-the-gap-why-womens-health-needs-a-system-redesign/): Women are living longer than men, but they are not living healthier lives. In over 700 diseases, women are diagnosed later by an average of four years. Across every region and income level, women spend approximately 25% more of their lives in poor health.
- [Empowering women to eliminate cervical cancer](https://rochediagram.com/dialogue/empowering-women-to-eliminate-cervical-cancer/): What if women didn’t have to face the arduous travel and cultural stigma that prevents her from accessing HPV testing?
- [How five diagnostic innovations are reshaping Asia-Pacific patient care](https://rochediagram.com/inside-the-lab/how-five-diagnostic-innovations-are-reshaping-asia-pacific-patient-care/): Diagnostics in the Asia-Pacific region are becoming less invasive, more accessible, and more precise - so we can give patients the answers they need earlier.
- [We need to rethink liver cancer detection in Hong Kong ](https://rochediagram.com/inside-the-lab/we-need-to-rethink-liver-cancer-detection-in-hong-kong/): New serum biomarkers can detect liver cancer risk earlier, so patients have time to make lifestyle changes 
- [Empowering people living with diabetes to live well, and sleep well ](https://rochediagram.com/future-of-healthcare/empowering-people-living-with-diabetes-to-live-well-and-sleep-well/): AI-enabled predictive continuous glucose monitoring devices can help prevent the overnight ‘lows’ feared by millions of people across the Asia-Pacific region
- [A new approach to tackle tuberculosis can save millions of lives ](https://rochediagram.com/inside-the-lab/a-new-approach-to-tackle-tuberculosis-can-save-millions-of-lives/): Molecular diagnostics, integrated lab infrastructure and multi-organisation partnerships are a powerful triple opportunity to prevent TB transmission 
- [5 ways modern mass spectrometry is reshaping lab operations](https://rochediagram.com/inside-the-lab/5-ways-modern-mass-spectrometry-is-reshaping-lab-operations/): The benefits of mass spectrometry are now scalable for the first time — and that gives pathology labs a new value proposition
- [Beyond the A1c: Why the Future of Diabetes and Heart Health is Predictive](https://rochediagram.com/dialogue/beyond-the-a1c-why-the-future-of-diabetes-and-heart-health-is-predictive/): Clinicians Prof Elaine Chow, Prof Rodica Busui and Prof Ronald Ma explain at APAC ProCardio how proactive, precision monitoring could mitigate the risk of cardiovascular complications in people with diabetes.
- [Digitising Early Detection in China](https://rochediagram.com/future-of-healthcare/digitising-early-detection-in-china/): A New Model for Liver Cancer Screening and Care
- [The potential impact of predictive glucose monitoring on life with diabetes](https://rochediagram.com/inside-the-lab/the-potential-impact-of-predictive-glucose-monitoring-on-life-with-diabetes/): What if diabetes didn’t take such a heavy emotional toll on the many millions of people who live with it? 
- [Could new blood tests give people living with Alzheimer’s enough time to improve their prognosis? ](https://rochediagram.com/inside-the-lab/could-new-blood-tests-give-people-living-with-alzheimers-enough-time-to-improve-their-prognosis/): What if a new way to test for Alzheimer’s gave underserved communities more time to make lifestyle changes — and delay the onset of cognitive decline?
- [Could mass spectrometry hold the key to tackling antimicrobial resistance?](https://rochediagram.com/inside-the-lab/could-mass-spectrometry-hold-the-key-to-tackling-antimicrobial-resistance/): What if more precise testing could ensure every patient is given the right dosage of antibiotics — whatever their clinical condition?
- [How clinical AI can identify at-risk patients before they’re seriously ill](https://rochediagram.com/inside-the-lab/how-clinical-ai-can-identify-at-risk-patients-before-theyre-seriously-ill/): What if overstretched clinical teams had early warning when a patient’s health is deteriorating?
- [Strategic, public-private partnerships can transform neurology outcomes](https://rochediagram.com/future-of-healthcare/strategic-public-private-partnerships-can-transform-neurology-outcomes/): What if a new partnership model could reduce costs and improve outcomes for patients and health systems alike? 
- [Move Care Upstream: How Roche and the HKSAR Government Are Driving Primary Healthcare Reform Ambition](https://rochediagram.com/inside-the-lab/move-care-upstream-how-roche-and-the-hksar-government-are-driving-primary-healthcare-reform-ambition/): Hong Kong has set out an ambitious vision: to position itself as an international health and medical innovation hub, anchored in strong primary healthcare, scientific excellence and deeper integration within the Greater Bay Area (GBA). Yet achieving that vision requires more than infrastructure or investment. It requires ecosystem-wide collaboration.
- [New Zealand’s proactive HBV screening programme is saving lives](https://rochediagram.com/inside-the-lab/new-zealands-proactive-hbv-screening-programme-is-saving-lives/): What if a new approach to testing could identify people living with a deadly disease that begins with no symptoms? 
- [The science of Alzheimer’s Disease explained](https://rochediagram.com/dialogue/the-science-of-alzheimers-disease-explained/): Lifestyle changes may slow progression of cognitive impairment — but early diagnosis is vital
- [Activating Indonesia’s Cervical Cancer Screening System](https://rochediagram.com/future-of-healthcare/activating-indonesias-cervical-cancer-screening-system/): Note: This article was adapted from an opinion editorial article written by Dr. dr. Dewi Wulandari, M.Sc, Sp.PK(K), Head of the Immunology and Biomolecular Division, Clinical Pathology Department, Faculty of Medicine, Universitas Indonesia. The article was published on The Jakarta Post, “Can Our Labs Achieve Cervical Cancer Screening Targets” on 24 December 2025. The original article can be accessed here.
- [Improving health equity in endocrinology](https://rochediagram.com/inside-the-lab/improving-health-equity-in-endocrinology/): Vitamin D testing in certain patient groups is highly variable — but new diagnostic technologies can create equity
- [Harnessing the power of next-gen sequencing in Asia Pacific](https://rochediagram.com/inside-the-lab/harnessing-the-power-of-next-gen-sequencing-in-asia-pacific/): What if new advanced chemistry technologies could improve scalability and increase efficiency to better understand Asia-Pacific’s leading causes of disease?
- [Strengthening the Front Line of Liver Cancer Surveillance](https://rochediagram.com/dialogue/strengthening-the-front-line-of-liver-cancer-surveillance/): Lessons from Chang Gung Memorial Hospital
- [Standardising the gold standard: the future of clinical mass spectrometry](https://rochediagram.com/inside-the-lab/standardising-the-gold-standard-the-future-of-clinical-mass-spectrometry/): Replacing fragmented, manual lab workflows with sample-to-result automation benefits patients, labs and health systems
- [The Reality Of Precision Medicine In Korea](https://rochediagram.com/future-of-healthcare/the-reality-of-precision-medicine-in-korea/): How a multi-institutional collaboration in Korea is translating genomics, data and multidisciplinary decision-making into routine cancer care.
- [Why early detection matters](https://rochediagram.com/dialogue/why-early-detection-matters/): Some stories don’t begin with symptoms or warnings. They begin with a decision.
- [Cervical cancer in Asia Pacific: a preventable crisis hiding in plain sight](https://rochediagram.com/inside-the-lab/cervical-cancer-in-asia-pacific-a-preventable-crisis-hiding-in-plain-sight/): Despite proven tools to eliminate cervical cancer, gaps in access, implementation and prioritisation mean too many women across Asia Pacific are still diagnosed too late.
- [Cervical cancer screening: how to transform our approach to HPV detection](https://rochediagram.com/future-of-healthcare/cervical-cancer-screening-how-to-transform-our-approach-to-hpv-detection/): A three-pronged approach to HPV DNA testing can reach women in resource-limited areas who would otherwise go undiagnosed.
- [Next-gen sequencing gives cancer patients the answers they need](https://rochediagram.com/future-of-healthcare/next-gen-sequencing-gives-cancer-patients-the-answers-they-need/): Next-gen DNA sequencing (NGS) gives cancer patients the answers they need, much earlier in their journey — empowering them with trust in their treatment pathway and the confidence to make informed decisions.
- [How Nucleic Acid Testing can prevent blood infections — and save lives](https://rochediagram.com/dialogue/how-nucleic-acid-testing-can-prevent-blood-infections-and-save-lives/): Transfusion-transmitted infections cause preventable deaths — but what if we could detect them before blood is administered?
- [Digital pathology tools can address the capacity challenge in Asia-Pacific labs](https://rochediagram.com/inside-the-lab/title-digital-pathology-tools-can-address-the-capacity-challenge-in-asia-pacific-labs/): What if we could automate the manual tasks that create capacity bottlenecks in pathology labs — so patients get the answers they need sooner?
- [Next-generation cardiac biomarkers could prevent CVD misdiagnoses for women across APAC](https://rochediagram.com/dialogue/next-generation-cardiac-biomarkers-could-prevent-cvd-misdiagnoses-for-women-across-apac/): A wide body of research shows that cardiovascular disease presents differently in women and men — so why are so many women still being misdiagnosed?
- [How to close Asia-Pacific’s diabetes detection gap](https://rochediagram.com/future-of-healthcare/how-to-close-asia-pacifics-diabetes-detection-gap/): More than half a billion people in our region will be living with diabetes by 2050 — and nearly 40% of them don’t yet know it. But what if early detection could change everything?
- [How a new disease management solution has tripled HCC early detection rates](https://rochediagram.com/future-of-healthcare/how-a-new-disease-management-solution-has-tripled-hcc-early-detection-rates/): In China, a pilot project to screen 12,000 individuals at high risk of liver cancer with new tools has achieved an early-stage diagnosis rate of more than 85% — far exceeding the national rate of less than 30%.
- [How a simple blood test offers an easy, accurate objective alternative to Transvaginal Ultrasound to simplify PCOS diagnosis](https://rochediagram.com/future-of-healthcare/how-a-simple-blood-test-offers-an-easy-accurate-objective-alternative-to-transvaginal-ultrasound-to-simplify-pcos-diagnosis/): Could a new alternative to ultrasound create standardised diagnostic criteria for PCOS and help millions of women achieve their desired family size?
- [From Cardiologist to Patient](https://rochediagram.com/dialogue/from-cardiologist-to-patient/): For over 20 years, Dr Suvanich Triamchanchoochai has been consulting patients with heart disease in Bangkok, Thailand. Here he shares his story of living through a heart attack and the lessons he now shares with patients.
- [Thailand’s Journey to Laboratory Excellence](https://rochediagram.com/inside-the-lab/thailands-journey-to-laboratory-excellence/): Mrs Naiyana Wattanasri, the outgoing Chairman and Founder of the Thailand Medical Technology Council, helped develop a systems quality roadmap for laboratory accreditation for the entire country. In this exclusive interview with Roche Diagram magazine, she speaks about the Laboratory Benchmarking Survey and experiences improving laboratory performance in Thailand.
- [The Decade of Diagnostics](https://rochediagram.com/future-of-healthcare/the-decade-of-diagnostics/): A look at the Past, Present and Future of Healthcare as we usher in the decade of diagnostics.
- [Understanding the Pregnancy Journey in Asia Pacific](https://rochediagram.com/dialogue/understanding-the-pregnancy-journey-in-asia-pacific/): Pregnancy can be a joyful yet demanding period in a woman’s life. For many expectant mothers, it often throws up a million and one questions. Moska Najib reports for Roche Diagram magazine on what women seek during their pregnancy journey, especially when it comes to the health of their babies, based on a study conducted by Roche Diagnostics.
- [Ten Questions with Dr V G Somani](https://rochediagram.com/future-of-healthcare/ten-questions-with-dr-v-g-somani/): Dr V G Somani is the Joint Drugs Controller of India (JDCI) Medical Devices and the in-vitro diagnostics (IVD) Central Drugs Standard Control Organisation (CDSCO). He heads the regulation of medical devices, in-vitro diagnostics, stem cells and blood products. In this interview with Roche Diagram magazine, he discusses the regulatory industry and the future of diagnostics in India.
- [Transforming Care for Thyroid Cancer Patients](https://rochediagram.com/inside-the-lab/transforming-care-for-thyroid-cancer-patients/): Dr Akira Miyauchi is President and Chief Operations Officer of Kuma Hospital, Centre of Excellence in Thyroid Care, Kobe, Japan. In 1993, Dr Miyauchi proposed a clinical trial for patients diagnosed with low-risk papillary micro carcinomas of the thyroid. The trial, which started the same year, allowed patients to choose between immediate surgery – the accepted standard of care – or active surveillance of the disease. In this interview with Roche Diagram magazine, Dr Miyauchi discusses the results of the 26-year study and how it is impacting the way doctors around the world are treating low-risk papillary micro carcinomas of the thyroid.
- [Towards a More Human Lab](https://rochediagram.com/inside-the-lab/towards-a-more-human-lab/): In the last quarter of 2018, laboratory industry leaders from across the world converged in Guangzhou, China, for the Roche Efficiency Day (RED). While exploring the theme ‘REDefine perspectives’, many presenters and many presenters and panelists reflected on how artificial intelligence (AI), big data, automation, and other digital technologies in healthcare continue to re-shape the future of the healthcare industry. But amid those discussions, another theme emerged – the enduring value of human intelligence and interpersonal relationships. While acknowledging the transformative power of digital technology and automation, several laboratory leaders emphasised the vital role that smart, passionate people will play in the future of the laboratory industry. Roche Diagram magazine spoke to a handful of those leaders to find out why they believe the laboratory of the future will be more – not less – human.
- [The Prevalence of Thalassemia](https://rochediagram.com/inside-the-lab/the-prevalence-of-thalassemia/): Over the past decade, knowledge relating to the clinical diagnosis and management of thalassemia has progressed extensively. In Thailand’s case, the country has made significant strides in just two decades. Dr Vip Viprakasit, Professor of Paediatrics at the Department of Paediatrics and Thalassemia Center at Siriraj Hospital, Mahidol University, Bangkok, has played a pivotal role in firmly placing thalassemia on the national agenda. In this interview with Roche Diagram magazine, Dr Viprakasit shares how Thailand has become a model for countries in Asia and the Middle East.
- [Ten Questions with Dr Arni Talib](https://rochediagram.com/dialogue/ten-questions-with-dr-arni-talib/): Dr Arni Talib is the Head of the National Pathology Services in Malaysia and the Head of the Department of Pathology at Kuala Lumpur Hospital. Her laboratory serves as the National Referral Centre for the Ministry of Health (MOH) which provides diagnostics services to the whole country. In this interview with Roche Diagram magazine, Dr Talib talks about her vision for the pathology industry in Malaysia.
- [Two Doctors, One Idea](https://rochediagram.com/dialogue/two-doctors-one-idea/): Can the diagnosis of heart attacks in one hour be made a reality in Asia? It was by sheer coincidence that Dr Kenji Inoue, Associate Professor, Department of Cardiology, Juntendo University Nerima Hospital in Tokyo, Japan and Dr Lee Chien-Chang, Associate Professor of Emergency Medicine at the National Taiwan University Hospital in Taipei, met.
- [Rising to the Threat of Antimicrobial Resistance in Asia](https://rochediagram.com/dialogue/rising-to-the-threat-of-antimicrobial-resistance-in-asia/): Experts in Asia call for concerted effort to control the catastrophic increase in cases of antimicrobial resistance.

## Pages
- [Dia:logue](https://rochediagram.com/dialogue/): No articles found.
- [Media Hub](https://rochediagram.com/media-hub/): Journalists and media professionals are welcome to request interviews with Roche subject matter experts.
- [Magazines](https://rochediagram.com/magazine/): Roche Diagram Magazine Roche Diagram is a regional healthcare magazine published by Roche Diagnostics Asia Pacific. It's a platform designed to spark conversations around the importance and value of diagnostics. The magazine explores how diagnostics shape healthcare—from early detection and risk stratification to monitoring and disease management. It highlights inspiring stories of healthcare innovators, clinicians, patients, and labs across the Asia Pacific region Home Past Magazines Edition 2024, Vol 14 Edition 2023, Vol 13 Edition 2022, Vol 12 Edition 2022, Vol 11 Edition 2021, Vol 9 Edition 2021, Vol 8 Edition 2021, Vol 10 Edition 2020, Vol 7 Edition 2019, Vol 6 Edition 2019, Vol 5 Edition 2018, Vol 4 Edition 2018, Vol 3 Edition 2017, Vol 2 Edition 2017, Vol 1
- [Inside the lab](https://rochediagram.com/inside-the-lab/): No articles found.
- [Future of Healthcare](https://rochediagram.com/future-of-healthcare/): No articles found.
- [Roche Perspectives](https://rochediagram.com/roche-perspectives/): No articles found.
- [About Dia:gram](https://rochediagram.com/about-diagram/): Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotechnology company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system.
- [Home](https://rochediagram.com/): About Us